Apellis Pharmaceuticals buy Saftman
Start price
17.03.23
/
50%
€57.93
Target price
17.03.24
-
Performance (%)
3.57%
End price
31.01.24
€60.00
Summary
This prediction ended on 31.01.24 with a price of €60.00. With a performance of 3.57%, the BUY prediction by Saftman for Apellis Pharmaceuticals closed with a slight gain. Saftman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 3,59 % | 6,43 % | 15,38 % | 52,31 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % | 41,46 % | 91,77 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % | 48,95 % | 65,86 % |
| iShares S&P 500 | 4,14 % | 4,94 % | 31,59 % | 65,33 % |
Comments by Saftman for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Saftman hat das Wertpapier Apellis Pharmaceuticals in seinem Wikifolio Langfristige Aufwärtstrends gekauft.